Selling Brazilian Cosmetics in the US: MoCRA Requirements for Brazilian Brands

By Vincent Cruz

Brazil is one of the largest beauty markets in the world, and Brazilian brands — hair care above all — have real demand in the United States. But Brazil’s regulator, ANVISA, and America’s FDA run completely different systems. A product that is fully legal, registered, and selling well in Brazil has no automatic standing in the U.S., and some of Brazil’s best-known product categories face extra scrutiny the moment they cross the border.

This guide is written for the Brazilian brand owner planning a U.S. launch: what MoCRA requires of you, where ANVISA and FDA rules diverge, and the specific mistakes that catch Brazilian brands. For the full compliance picture, start with the MoCRA Compliance Guide for Cosmetic Brands.

The core rule: ANVISA approval does not transfer

Everything in this guide follows from one fact: FDA does not recognize ANVISA compliance as a substitute for U.S. compliance. Specifically:

  • Your ANVISA notification or registration means nothing to FDA. The U.S. has its own facility registration and product listing system, and every filing must be made there.
  • Your ANVISA product grade does not decide U.S. status. ANVISA classifies cosmetics as Grade 1 (basic products, handled by notification) and Grade 2 (products with specific purposes — sunscreens, hair straighteners and dyes, children’s products, insect repellents — which require full registration). FDA does not use that scale. In the U.S., the only question that matters is whether your product is a cosmetic or a drug under U.S. law, and that is decided by your ingredients and your claims — not by how ANVISA graded it.
  • Your responsible company in Brazil has no standing with FDA. MoCRA has its own “responsible person” concept (the manufacturer, packer, or distributor whose name appears on the label), and it is a different legal role.
  • Your ANVISA GMP certification is useful evidence of good practice, but it satisfies no U.S. filing requirement.

Plan your U.S. launch as a fresh compliance project, not an extension of your Brazilian paperwork.

Step 1: Register your facility with FDA

If your products are manufactured or processed in Brazil (or anywhere outside the U.S.) for sale in America, the facility must register with FDA. Key points for Brazilian brands:

  • You need an FEI number first. The FDA Establishment Identifier is required before registration can be filed. Request it from FDA by email; processing typically takes 7 to 10 business days. Run the free FEI check to see whether your facility already has one.
  • Registration is filed through Cosmetics Direct, FDA’s online portal, using Form FDA 5066. The step-by-step process is covered in Cosmetics Direct: How to Register Your Facility.
  • Registration renews every two years, based on your facility’s initial registration date, with automated reminders from FDA. See MoCRA Biennial Renewal Explained.
  • Using a contract manufacturer in Brazil? The facility that manufactures the product is the one that registers. If you outsource production, that manufacturer’s facility registers (and it needs its own U.S. agent). See Private Label Cosmetics: Who Registers Under MoCRA.

A common Brazilian-brand mistake: assuming your American distributor’s or importer’s registration covers you. It does not. The manufacturing facility registers; a distributor cannot register on the manufacturer’s behalf.

Step 2: Name a U.S. agent

Every foreign facility registering with FDA must designate a U.S. agent: a person or business physically present in the United States who serves as FDA’s official contact for the facility. This is not optional, and a Brazilian address or your ANVISA responsible company cannot fill the role.

The agent receives FDA correspondence, relays it to you, and is the contact FDA reaches out to with questions about your facility. Our own service is a flat $450 one-time onboarding plus $34.99 per month per facility — whoever you choose, insist on seeing the full numbers before you sign. For how to evaluate providers, see How to Choose a MoCRA U.S. Agent and Who Can Be a MoCRA U.S. Agent.

Step 3: List your products

Each cosmetic product sold in the U.S. must be listed with FDA through Cosmetics Direct (Form FDA 5067), filed by the responsible person. Listings include product and ingredient information and must be kept current with annual updates.

Note the Brazil difference: ANVISA Grade 1 products are notified and Grade 2 products are registered before they are sold in Brazil. Neither action creates any record with FDA. Your U.S. listings are separate filings, in a different format, with different legal consequences. Do both; neither substitutes for the other. For how registration and listing differ, see Facility Registration vs Product Listing Explained.

Step 4: Fix your labels for the U.S. market

Brazilian labels do not automatically comply with U.S. labeling law. The differences that matter most:

Ingredient declaration. Both markets use INCI-style nomenclature, so your ingredient list mostly transfers. But the U.S. requires ingredients in descending order of predominance with specific formatting rules, and FDA is developing fragrance allergen labeling regulations that will add new disclosure requirements.

Net quantity. U.S. consumer commodities must state net quantity in both U.S. customary and metric units, placed in a specific location on the principal display panel. Brazilian labels showing metric only need updating.

Name and place of business. The label must show the name and place of business of the manufacturer, packer, or distributor. A Brazilian address alone is acceptable only if the product is not misleading about origin; many Brazilian brands add their U.S. distributor’s information.

Domestic contact for adverse events. MoCRA requires labels to carry a U.S. domestic contact — an address, phone number, or electronic contact — through which consumers can report adverse events. A Brazilian contact alone does not satisfy this.

Language. All required label information must be in English. Portuguese labeling, however complete in Brazil, does not comply in the U.S.

Warnings and directions. Certain product types require specific warning statements under U.S. rules — hair products are the big one for Brazilian brands, covered below. Products also regulated as drugs need Drug Facts labeling instead.

Claims review. Marketing claims written for the Brazilian market can be drug claims in the U.S. “Reconstructs hair fiber,” “stimulates growth,” or SPF claims need re-evaluation before the product ships. See Is Your Product a Cosmetic or a Drug?.

For the detailed labeling changes MoCRA introduced, see MoCRA Labeling Changes.

The formaldehyde problem: hair-straightening products

This is the pitfall that defines the Brazil-to-US route. Keratin straightening treatments of the “Brazilian blowout” type are a signature Brazilian export — and they sit at the center of FDA’s formaldehyde scrutiny.

Many straightening formulas rely on formaldehyde or on ingredients such as methylene glycol that release formaldehyde when heated during application. FDA has warned about these products for years and has proposed a rule to ban formaldehyde and formaldehyde-releasing chemicals in hair-smoothing products; several states have moved ahead with their own restrictions. ANVISA permits certain formaldehyde uses in Brazil under its own limits; that permission has no effect in the U.S.

Practical consequences for Brazilian hair brands:

  • Your ANVISA Grade 2 registration does not settle the question. A straightener fully registered in Brazil can still be detained, refused, or pulled in the U.S. See FDA Detained Your Cosmetic Shipment? for how refusals work.
  • Safety substantiation is where the fight happens. Under MoCRA the responsible person must hold adequate substantiation of safety for every product, and formaldehyde-releasing formulas are exactly where that file gets tested. See MoCRA Safety Substantiation.
  • Manufacturing controls matter too. Salon products applied with heat draw exposure questions for stylists as well as customers; your GMP documentation needs to answer them. See MoCRA GMP Requirements.

If your hero product is a straightening treatment, get its formula and claims reviewed against U.S. rules before you spend on registration, labels, or inventory.

The pitfalls that catch Brazilian brands specifically

  • Assuming ANVISA approval equals FDA compliance. It does not, in any respect. Separate filings, separate labels, separate agent.
  • Trusting the ANVISA grade to predict U.S. classification. A Grade 1 cosmetic in Brazil can be a drug in the U.S. if its claims promise to treat, grow, or change the body — and a Grade 2 product is not automatically a U.S. drug either. Classification is decided product by product, under U.S. definitions.
  • Relying on the distributor. Your U.S. distributor or retail partner may offer to “handle compliance.” They cannot register your Brazilian facility or serve as your facility’s U.S. agent unless they formally take on that role and meet FDA’s requirements. Keep control of your own filings.
  • Small-business exemption confusion. The U.S. small-business exemption (Section 612 of the FD&C Act, 21 U.S.C. section 364h) is based on U.S. sales, not Brazilian revenue, and it never exempts labeling, safety substantiation, or adverse event reporting. Check the exemption worksheet rather than assuming.
  • Forgetting the ongoing duties. Registration is not a one-time event: biennial renewal, annual listing updates, adverse event reporting within 15 business days for serious events, and records kept for 6 years. See MoCRA Adverse Event Reporting.

A realistic Brazil-to-US launch sequence

  1. Classify every product as cosmetic or drug for the U.S. market (re-do claims and ingredients, not just labels) — and screen hair-straightening formulas for formaldehyde issues first.
  2. Confirm whether you qualify for the small-business exemption; if not, proceed with full compliance.
  3. Request your facility’s FEI number (7 to 10 business days).
  4. Choose and appoint your U.S. agent.
  5. File facility registration via Cosmetics Direct.
  6. File product listings.
  7. Finalize U.S.-compliant labels before the first shipment.
  8. Set up adverse event intake and record-keeping from day one.

For realistic timing on each step, see How Long Does MoCRA Facility Registration Take?.

FAQ

Do I need a U.S. agent if I sell through an American distributor?
Yes, if your products are manufactured outside the U.S. The foreign manufacturing facility must designate its own U.S. agent as part of facility registration. Your distributor cannot substitute for this unless it formally serves as the agent and meets FDA’s requirements.

Does my ANVISA registration count as a U.S. product listing?
No. The ANVISA system and the U.S. listing system are completely separate. You must list products with FDA through Cosmetics Direct regardless of ANVISA status — for Grade 1 and Grade 2 products alike.

My straightener is registered as Grade 2 with ANVISA. Is it fine in the US?
Not automatically. ANVISA grades do not decide U.S. status: a formaldehyde-releasing formula faces FDA scrutiny and possible state restrictions regardless of its Brazilian registration, and its claims are judged under U.S. cosmetic-versus-drug rules.

Can my Brazilian responsible company be my U.S. agent?
No. The U.S. agent must be physically present in the United States (residing there or maintaining a U.S. place of business). A Brazil-based person or company does not qualify.

Are Brazilian cosmetic labels acceptable in the US?
Usually not without changes. English language, net quantity declarations, name and place of business, the domestic adverse-event contact, warning statements, and claims all need review against U.S. requirements. Ingredient nomenclature mostly transfers, but formatting rules differ.

How long does the whole process take for a Brazilian brand?
The FEI request alone takes 7 to 10 business days, and gathering registration details, appointing an agent, and finalizing labels adds more time. Plan for several weeks minimum from a standing start; see How Long Does MoCRA Facility Registration Take? for the full breakdown.


Next step: Brazilian brand planning a U.S. launch? Contact us for a straight assessment of what your products need, or run the free FEI check to confirm whether your facility already has an FDA Establishment Identifier.

This article is for educational purposes only and is not legal advice. US MoCRA Agent is a private service provider and is not affiliated with or endorsed by the FDA.

Scroll to Top